Time has just ripen to introduce the API integrated, research-driven oncology finished dosage formulation unit by Sakar. “It has been long since we have been preparing to enter the niche segment to cater to humanity; our anti-cancer unit will open the doors to same” says company founder and Managing Director Mr.Sanjay Shah.
With widened market presence with existing product segments topped up with inclusion of oncology products, Sakar has definitely drawn interests of diverse stake holders and potential partners and investors.
Over 50 value adding business partners from domestic and international markets have expressed the necessary impetus and encouragement to Sakar towards this new bespoke unit. Now, Sakar is all set to execute the projects on hand that include research and product developments from Europe as well as manufacturing products for domestic clients.